International Flavors & Fragrances Inc. (IFF) has announced the completion of its divestiture of the Flavor Specialty Ingredients (FSI) business to Exponent, a UK-based private equity firm. The transaction, which was previously announced in February 2023, garnered cash proceeds of $220 million. International Flavors & Fragrances Divests Flavor Specialty Ingredients Division The Flavor Specialty Ingredients […]
US-based International Flavors & Fragrances (IFF) has agreed to sell Savory Solutions Group to French private equity firm PAI Partners for an enterprise value of approximately $900 million. International Flavors & Fragrances will use cash proceeds net of taxes and expenses to reduce outstanding debt. The sale of Savory Solutions Group is anticipated to help […]
Merck has achieved a significant milestone by obtaining approval from the European Commission (EC) for its cancer immunotherapy, Keytruda (pembrolizumab), to be used in combination with Eli Lilly’s chemotherapy drug pemetrexed (ALIMTA) and platinum chemotherapy. This approval specifically targets the first-line treatment of metastatic nonsquamous non-small cell lung cancer (NSCLC) in adults who do not […]